4d Pharma PLC (GB:DDDD)
LSE:DDDD
UK Market

4d Pharma Stock Analysis & Ratings

GB:DDDD Stock Chart & Stats

Day’s Range32.05p - 35.25p
52-Week Range23.50p - 183.00p
Previous Close33.5p
Volume461.40K
Average Volume (3M)3.38M
Market Cap60.48M
P/E Ratio-1.1
Beta2.96
Next EarningsSep 29, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score1
EPS (TTM)-0.34


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:DDDD FAQ

What was 4d Pharma’s price range in the past 12 months?
4d Pharma lowest stock price was 23.50p and its highest was 183.00p in the past 12 months.
    What is 4d Pharma’s market cap?
    4d Pharma’s market cap is 60.48M.
      What is 4d Pharma’s price target?
      Currently, no data Available
      What do analysts say about 4d Pharma?
      Not enough analysts have published a price target to provide an average price target.
      When is 4d Pharma’s upcoming earnings report date?
      4d Pharma’s upcoming earnings report date is Sep 29, 2022 which is in 126 days.
        How were 4d Pharma’s earnings last quarter?
        4d Pharma released its earnings results on Mar 31, 2022. The company reported -2.6p earnings per share for the quarter, missing the consensus estimate of 0p by -2.6p.
          Is 4d Pharma overvalued?
          According to Wall Street analysts 4d Pharma’s price is currently Overvalued.
            Does 4d Pharma pay dividends?
            4d Pharma does not currently pay dividends.
            What is 4d Pharma’s EPS estimate?
            4d Pharma’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does 4d Pharma have?
            4d Pharma has 180,300,000 shares outstanding.
              What happened to 4d Pharma’s price movement after its last earnings report?
              4d Pharma reported an EPS of -2.6p in its last earnings report, missing expectations of 0p. Following the earnings report the stock price went down -15.645%.
                Which hedge fund is a major shareholder of 4d Pharma?
                Currently, no hedge funds are holding shares in GB:DDDD

                ---

                4d Pharma Stock Analysis

                Smart Score
                1
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                Price Target
                No data currently available

                Analyst Forecast

                N/A
                Currently Not Enough Data Available

                Blogger Sentiment

                N/A
                Currently Not Enough Data Available

                Hedge Fund Holdings

                N/A
                Currently Not Enough Data Available

                Insider Transactions

                N/A
                Currently Not Enough Data Available

                Retail Investors

                N/A
                Currently Not Enough Data Available

                News Sentiment

                N/A
                Currently Not Enough Data Available

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -66.96%
                12-Months-Change

                Fundamentals

                Return on Equity
                -210.91%
                Trailing 12-Months
                Asset Growth
                21.23%
                Trailing 12-Months
                The 4d Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                4d Pharma PLC

                4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Avacta Group plc
                Omega Diagnostics
                Synairgen
                Genedrive
                Circassia Pharmaceuticals

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis